Significance of defining a pathogenic variant in hereditary cancer syndrome
Abstract
Keywords
Full Text:
PDFReferences
Nagy R, Sweet K, Eng C. Highly penetrant hereditary cancer syndromes. Oncogene 2004; 23(38): 6445–6470. doi: 10.1038/sj.onc.1207714.
Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res 2015; 43(DI): D789–D798. doi: 10.1093/nar/gku1205.
Warthin AS. Heredity of carcinoma in man. Ann Intern Med 1931; 4(7): 681–696. doi: 10.7326/0003-4819-4-7-681.
Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ. Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med 1966; 117(2): 206–212. doi: 10.1001/archinte.1966.03870080050009.
Boland CR, Troncale FJ. Familial colonic cancer without antecedent polyposis. Ann Intern Med 1984; 100(5): 700–701. doi: 10.7326/0003-4819-100-5-700
Lu KH, Dinh M, Kohlmann W, Watson P, Green J, et al. Gynecologic cancer as a sentinel cancer for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol 2005; 105(3): 569–574. doi: 10.1097/01.AOG.0000154885.44002.ae.
Huang F, Tao X, Jiang W, Chen J, Feng W. Identification and verification of a pathogenic MLH1 Mutation c.1145dupA in a Lynch syndrome family. Adv Mod Oncol Res 2017; 3(3). doi: 10.18282/amor.v3.i3.213. (In Press)
Landrum MJ, Lee JM, Benson M, Brown G, Chao C, et al. ClinVar: Public archive of interpretations of clinically relevant variants. Nucleic Acids Res 2016; 44(D1): D862–D868. doi: 10.1093/nar/gkv1222.
Richards S, Aziz N, Bale S, Bick D, Das S, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17(5): 405–424. doi: 10.1038/gim.2015.30.
Hunter JE, Arnold KA, Cook JE, Zepp J, Gilmore MJ, et al. Universal screening for Lynch syndrome among patients with colorectal cancer: Patient perspectives on screening and sharing results with at-risk relatives. Fam Cancer 2017. doi: 10.1007/s10689-017-9972-2.
Watkins JC, Yang EJ, Muto MG, Feltmate CM, Berkowitz RS, et al. Universal screening for mismatch-repair deficiency in endometrial cancers to identify patients with Lynch syndrome and Lynch-like syndrome. Int J Gynecol Pathol 2017; 36(2): 115–127. doi: 10.1097/PGP.0000000000000312.
Hampel H. Genetic counseling and cascade genetic testing in Lynch syndrome. Fam Cancer 2016; 15(3): 423–427. doi: 10.1007/s10689-016-9893-5.
Yurgelun MB, Chenevix-Trench G, Lippman SM. Translating germline cancer risk into precision prevention. Cell 2017; 168(4): 566–570. doi: 10.1016/j.cell.2017.01.031.
DOI: http://dx.doi.org/10.30564/amor.v3i3.117
Refbacks
- There are currently no refbacks.
Copyright (c) 2018 Kwong-Kwok Wong

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.